xxii
DAFTAR PUSTAKA
1. Baziad A (1), 2003. Menopause dan Andropause. 1st ed. Jakarta: Yayasan Bina Pustaka Sarwono Prawirohardjo.
2. Djokomoeljanto R, 2003. Postmenopausal osteoporosis. Patofisiologi dan dasar pengobatan. Simposium Osteoporosis Postmenopausal. Semarang: p.1-12.
3. Raisz LG, 2005. Pathogenesis of osteoporosis concepts, conflicts and prospects. J.Clin Invest; 115 (12): p. 3318-25.
4. Sartika RAD. Pengaruh Asupan Asam Lemak Trans terhadap Profil Lipid Darah (Disertasi ). Program Doktor Ilmu Epidemiologi Program Pasca Sarjana Fakultas Kesehatan Masyarakat Universitas Indonesia 2007.
5. Mauger JF, Lichtenstein AH, Ausman LM, Jalbert SM, Jauhiainen M, Ehnholm C et
al. Effect of different forms of dietary hydrogenated fats on LDL particle size. Am J Clin Nutr 2003: 78;370-5.
6. US Departemen of Health and Human Services, Food and Drug Administration 2003.
7. Chatgilialoglu C, Ferreri C, Lykakis IN, wardman P. Tran- Fatty acids dan radical stress: What are the real culprits? J.bmc.2006.50-2.
8. Griendling KK, FitzGerald. Ovidative Stres and cardiovasculer injuri. Part I: basic mechanism and in Vivo Monitoring of ROS. Circulation 2003;108:1912-16. Gong D, Yang R, Munir KM, Horenstein RB, Shuldiner AR. New Progress in Adipocytokine Research. Curr Opin in Endo & Diab 2003; 10: 115-21.
9. McCord JM. Oxidative Stress and Aging; Advances in basic Science, Diagnostics and Intervention, Vol.II. Cutler RG, Rodriguez H. Singapore: World Scientific. 2003. p.883-5.
10.Szmitko PE, wang CH, Weisel RD, de Almeida JR, Anderson TJ, Verma S. New Markers of Inflamation and Endothelial Cell Activation: Part I. Circulation 2003; 108:1917-23.
xxiii
12.Ganero P, Delmas PD, 2004. Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in post menopausal women. Musculoskel Neuron Interact. 4(1): p.50-63.
13.Ott SM., 1999. Osteoporosis and Osteomalacia in Principles of Geriatric Medicine and Gerontology. 4th Ed., New York, Mc. Graw Hill: p. 1057–83.
14.Allison J L, Hodges S, Eastell R, 2000. Measurement of osteocalcin in Ann Clin Biochem, Review Article (37): p. 432-46.
15.Kaniawati, M., Moeliandari, F, 2003, Penanda Biokimia untuk Osteoporosis. Forum Diagnosticum Prodia Diagnostics Educational Services. No 1: hal. 1–18.
16.Hammett, Stabler CA, 2004. Osteoporosis from pathophysiology to treatment. In: Washington American Assosiation for Clinical Chemistry Press.p. 1-86.
17.Filip RS, Zagorski, 2004. Age and BMD-Related Difference in Biochemical Markers of Bone Metabolism in Rural and Urban Women from Lublin Region, Poland. Ann Agric Environ med. (11): p.255-59.
18.Dorfman SE, Laurent D, Gounarides JS, Li Xue, Mullarkey TL., Rocheford EC. Metabolic Implication of Dietary Trans- fatty Acids. Obesity journal org.2009;17,6:1200-07.
19.Roberts WL, sedrick R, Moulton L, Spencer A, Rifai N, Evaluation of Four Automated high- Sensitivity C-Reactive protein methods; Implications for Clinical and epidemiological applications. Clinical chemistry 2000;46/4:461-8.
20.Mozaffarian D, Katan MB, Ascherio A, Stampfer M, Willett WC. Trans Fatty Acids
and Cardiovasculer Disease. N Engl J Med 2006;354:1601-13.
21.Bensadoun A. Trans fatty Acids- Health and labeling Issues. Food an Nutrition. Ask the Nutrition Expert in Food and Nutrition. Cornell Cooperative Extension. Cornell University 2003.
22.Brehm BJ. Trans- Fatty Acids : Coming Soon to Your Food Labels. In Diet and Nutrition. University of Cincinnaty 2003.
23.Inis SM. The Trans Fatty Acid Composition and Content of Canadian Foods in Child and Family Research Institute Nutrition Research Program. University of British Columbia. JADA 2001.
xxiv
25.Martin JC, Nour M, Lavillonniere F, Sebedio JL. Effect of Fatty Acid Positional Distribution and Triacylglycerol Composition on Lipid By- Products Formation During Heat Treatment : II. Trans Isomers, J Am Oil Chem Soc. 1998: 75 (9): 1073-78.
26.Judd JT, Clevidence BA. Muesing RA, Wittes J, Sunkin ME, Podczasy JJ. Dietary Trans Fatty Acids: Effects on Plasma Lipids and Lipoproteins of Healthy Men and Women. Am J Clin Nutr. 1994: 59:861-68.
27.Sebedio JL, Chardigny JM. Physiological Effects of Trans and Cyclic Fatty Acids, In Perkins EG, Srickson. Deep Frying; Chemistry, Nutrition, and Practical Applications, AOCS Press. Campaign, Illinois.1996 p 181-209.
28.Bhagavan NV. Medical Biochemistry 4th ed. IAP Harcourt Academic Press. San Diego 2002. p. 388.
29.Wardlaw GM, Hampl JS, DiSilvestro RA. Lipids in Perspectives in Nutrition. 6th ed. Mc Graw Hill Boston 2004: 177- 210.
30.Murray, RK, Granner DK, Mayes PA, Rodwell VW. Biokimia Harper Edisi 25. EGC. 2005.
31.Oomen CM, Ocke MC, Feskens EJM, Kok FJ, van Erp- Baart MAJ, Kok FJ, et al.
Association between Trans Fatty Acids Intake and 10 Year Risk of Coronary Heart Disease in the Zulphen Elderly Study: a Prospective Population Based Study. Lancet 2001: 357: 746- 51.
32.Beynen AC, Katan MB. Impact of Dietary Cholesterol and Fatty Acids on Serum Lipids and Lipoproteins in Man. Academic Press Limited. Netherlands. 1989:p. 238- 256.
33.Dietschy JM. Dietary Fatty Acids and the Regulation of Plasma Low Density Lipoprotein Cholesterol Concentrations. American Society for Nutritional Sciences. The Journal of Nutrition.1998;128;2:444S-8S.
34.Chandrasekharan N, Basiron Y 2000. Palm Oil in human nutrition and health. Planter. 2000: 76(890);299-312.
xxv
36.Turpeinen AM, Wubert J, Aro A, Lorenz R, Mutanen M. Similar Effects of Diets Rich in Stearic Acid or trans- Fatty Acids on Platelet Function and Stearic Acid or Trans- Fatty Acids on Platelet Function and Endothelial Prostacyclin Production in Humans.. Aterioscler. Thromb Vasc Biol. 1998;18:316-322.
37.Nicolosi RJ, Wilson TS, Lawton C, Handelman GJ. Dietary Effects on
Cardiovascular Disease Risk Factors: Beyond Saturated Fatty Acids and Cholesterol. J Am Coll Nutr 2001; 20: 5,4128-427.
38.Madge LA. Pober JS. TNF signaling in vasculer endothelial cells. Exp Mol Pathol 2001;70:317-25.
39.Muller H. SeljeflotI. Solvoii K. Pedersen JL. Partially hydrogeneted soybean oil reduces posprandial t- PA activity compared with palm oil. Atherosclerosis 2001:155:467-76.
40.Isbagio H,. 2005. dalam : Panduan Diagnosis dan Pengelolaan Osteoporosis. Pengurus Besar Ikatan Rematologi Indonesia (IRA): hal. 1-31.
41.McCord JM. Oxidative Stress and Aging; Advances in basic Science, Diagnostics and Intervention, Vol.II. Cutler RG, Rodriguez H. Singapore: World Scientific. 2003. p.883-5.
42.Chandalia M, Cabo Chan AV, Sridevi D, Jialal I, Grundy SM, and Abate N. Elevated plasma high Sensitgivity C-eacvtive Protein Concentration in Asdia Indians Living in the United states. The Journal of Clinical Endocrrinology & Metabolism Vol 88,377- 9.
43.Buckwalter JA, Glinicher MJ, Cooper RR, Recher R. Bone biology. J.Bone Joint Surg.1995; 77(8): p.1256-72.
44.Riis BJ. The role of bone turnover in pathophysiology of osteoporosis. Br J Obstet Gynecol. 1996;103 (13): p. 9-15.
45.Lane NE. Lebih lengkap tentang osteoporosis rapuh tulang 1st ed. Jakarta: RajaGrafindo Persada. 2001.
46.Rachman IA. Osteoporosis primer (Post menopause osteoporosis). In: Osteoporosis. edisi I. Editor: Suherman SK, Tobing S Dohar AL. Perhimpunan Osteoporosis Indonesia. Indomedika.2006; p. 1-16.
xxvi
48.Morgan SL, Saag KG, Julian BA, Blair H. Osteopenic bone disease. Arthritis and allied condition 14th ed. Editors: Koopman WJ. Philadelphia. Lippincott Williams and Wilkins. (122).2001; p. 2449-97.
49.Rosenberg AE. Bones, joints and soft tissue tumors. In: Kumar V, Abbas AK, Fausto N, editors. Robbins and Contran Pathologic Basic of Disease 8th ed. Philadelphia: Elseiver Saunders. 2005;(26) ; p. 1273-83.
50.Hoffbrand A.V, Pettit J.E. Essential Haematology; alih bahasa, Iyan Darmawan. Ed.2. EGC Penerbit Buku Kedokteran. Jakarta. 1996;hal. 180-5.
51.Drajad RS. Struktur dan fungsi skeleton. In: Kursus dasar metabolism kalsium dan penyakit tulang. Editors. Soeatmadji DJokoW, Rudijanto A, Arsana PM. PERKENI,Malang. 2002;(III): p.1-9.
52.Van Essen HW, Holzmann PJ, Blankenstein MA, Lips P, Bravenboer N,2007. Effect
of Raloxifene Treatment on Osteocyte Apoptosis in Post Menopausal Women. Calsif Tissue Int.(81): p. 183-90.
53.Canalis E. The Fate of Circulating Osteoblast. N Engl J Med. 2005; (35)2: p. 19.
54.Soeatmadji Djoko W. Kendali hormonal metabolisme calsium dan skeletal. In: Kursus dasar metabolisme kalsium dan penyakit tulang. Editors. Soeatmadji Djoko W, Rudijanto A, Arsana PM. PERKENI, Malang. 2002;(IV)1-17.
55.Eder K, Schleser S, Becker K, Korting R. Conyugated Linoleic Acids Lower the Release of Eicosanods and Nitric Oxide from Human Aortic Endothelial cells. J. Nutr. 2003,133:4083-9.
56.Cantor WJ. Early cardiac chathetrization is associated with lower mortality only among high rusk patient TS and non TS elevation acut coronary syndromes: observations from the OPUS- TIMI 16 trial, Am Heart J 149(2);2005:275-83.
57.Ivaska K. Osteocalcin. Novel insights into the use of osteocalcin as a determinant of bone metabolism. Department of Anatomy, Institute ofBiomedicine, University of Turku, Turku, Finland, and The National Graduate School for Musculoskeletal Diseases (TULES) University of Turku, Finland. Clin Chem: 2005,p.1-113.
58.Soekidjo N. Metode Penelitian Eksperimen. Dalam Metode Penelitian Kesehatan. Rineka Cipta. 2010: 50-9.
xxvii
60.Taylor A.F. Osteoblastic glutamate receptor function regulates bone formation and resorption. J Musculoskel Neuron Interact. 2002; 2(3):285-90.
61.Van’t H., Ralston S. Nitric oxide and bone. Immunology 2001;103:255-261.
